Kaplan-Meier Curve of Survival Outcomes Among ITT Population.
Significantly improved survival noted among patients treated with flucytosine-containing combination therapy (Arm II, green line) compared with amphotericin monotherapy (Arm I, blue line) at 70 days and 182 days.Reproduced with permission from J. Day, MD.